Reckitt Benckiser (Bangladesh) PLC (DSE:RECKITTBEN)

Revance Therapeutics Revenue

Reckitt Benckiser (Bangladesh) had revenue of 1.34B BDT in the quarter ending June 30, 2025, a decrease of -1.13%. This brings the company's revenue in the last twelve months to 5.59B, up 5.87% year-over-year. In the year 2024, Reckitt Benckiser (Bangladesh) had annual revenue of 5.46B with 3.36% growth.

• Revenue (ttm): 5.59B
• Revenue Growth: +5.87%
• P/S Ratio: 2.87
• Revenue / Employee: 16.84M
• Employees: 332
• Market Cap: 16.05B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.46B	177.66M	3.36%
Dec 31, 2023	5.28B	312.21M	6.28%
Dec 31, 2022	4.97B	27.32M	0.55%
Dec 31, 2021	4.94B	-391.84M	-7.35%
Dec 31, 2020	5.33B	1.21B	29.27%